East Windsor, NJ—Sabinsa has been granted three new patents in Canada, according to a press release, and has received an additional Natural Products Number (NPN) from Health Canada, bringing the company’s total number of products with health claims in Canada to 37.
The patents are:
- Patent CA2976689, for a water-soluble form of Curcumin sold as uC3 Clear. The patent covers a method of solubilizing curcuminoids, which enhances solubility of curcumin to more than 10%-15% w/v in water.
- Patent CA2979287, for the anti-cancer properties of a compound isolated from Thai ginger, DMBPD. The compound can cause significant decrease in the expression of cell adhesion molecules as evaluated by studies on pancreatic carcinoma cells. It has been granted patents in the USA, Australia, Russia, New Zealand, and Japan.
- Patent CA2975170, which covers the use of OLEPENT cosmetic peptides in maintaining water hydration by increasing the expression of a water channel protein. The patent describes the increase in gene expression and associated proteins for improving skin barrier function in dehydrated human skin that comes from using OLEPENT.
Related: Sabinsa Granted Patent for Hair Serum in Mexico
KSM-66 Ashwagandha Granted New Functional Claims by Health Canada
Dr. Majeed Foundation Helps Alleviate Food Insecurity
The NPN is for uC3 Clear, which allows these claims:
- Provides antioxidants for maintenance of good health
- Used in herbal medicine to help relieve joint inflammation
“Our commitment to research and development is continuing to bring innovations that consumers can soon enjoy,” said Sabinsa Founder and Chairman Dr. Muhammed Majeed in the press release. “These patents provide the added assurance that low quality copycats won’t easily disrupt the marketplace, which protects our customers.”